Stay updated with breaking news from Patrick Barth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
? Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2020 - Roche
Investegate announcements from F. Hoffmann-La Roche Ltd, FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
F. Hoffmann-La Roche Ltd: Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81% Placebo Risk reduction 13 1.2 4 copies/mL) 14 0.4 * Individuals without any COVID-19 symptoms who lived in the same household as an individual who tested positive to SARS-CoV-2 within the prior four days . Based on the seronegative modified Full Analysis Set population, which includes all randomized subjects without evidence of current or prior SARS-CoV-2 infection (i.e., a negative RT...
(0) EVRYSDI 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy (SMA) OCREVUS data show its consistent benefit on slowing disease progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) reinforce safety and efficacy, including in patients with concomitant autoimmune diseases (CAIDs) Data for investigational MS medicine fenebrutinib support its safety profile and high potency Additional presentations on investigational programmes, including ...
F. Hoffmann-La Roche Ltd: Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs 1 on a single platform to optimise space and resources in small to medium laboratory settings With a footprint of just two square meters, this new analyser provides small to medium sized labs with access to more than 230 diagnostic tests 2 across a wide-range of disease areas including infectious diseases, oncology and cardiology Through automation of manual tasks, Roche's new solution is designed to simplify workflows and improve the productivity of lab ...